176 related articles for article (PubMed ID: 17445796)
61. The inhibition of experimentally induced visceral hyperalgesia by nifedipine - a voltage-gated Ca(2+) channels blocker (VGCCs) in sheep.
Kania BF; Kowalczyk M; Brytan M; Tomaszewska D; Przekop F
Res Vet Sci; 2009 Apr; 86(2):285-92. PubMed ID: 18774578
[TBL] [Abstract][Full Text] [Related]
62. Cilnidipine: Next Generation Calcium Channel Blocker.
Shete MM
J Assoc Physicians India; 2016 Apr; 64(4):95-99. PubMed ID: 27734656
[TBL] [Abstract][Full Text] [Related]
63. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats.
Hosono M; Hiruma T; Watanabe K; Hayashi Y; Ohnishi H; Takata Y; Kato H
Jpn J Pharmacol; 1995 Oct; 69(2):119-25. PubMed ID: 8569048
[TBL] [Abstract][Full Text] [Related]
64. Inhibitory effects of AE0047, a new dihydropyridine Ca(2+) channel blocker, on renal nerve stimulation-induced renal actions in anesthetized dogs.
Yamasaki T; Ohmagari M; Tamai I; Hayashi K; Matsumura Y
J Pharmacol Exp Ther; 2000 Jun; 293(3):1040-7. PubMed ID: 10869409
[TBL] [Abstract][Full Text] [Related]
65. AH-1058: a novel cardioselective Ca2+ channel blocker.
Takahara A; Sugiyama A; Yoshimoto R; Hashimoto K
Cardiovasc Drug Rev; 2001; 19(4):279-96. PubMed ID: 11830748
[TBL] [Abstract][Full Text] [Related]
66. Cardiovascular profile of FPL 62129, a novel dihydropyridine calcium channel blocker, in anaesthetised dogs: a comparison with nifedipine.
Humphries RG; O'Connor SE
J Cardiovasc Pharmacol; 1988 Mar; 11(3):332-8. PubMed ID: 2452927
[TBL] [Abstract][Full Text] [Related]
67. The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells.
Oda S; Oda T; Takabuchi S; Nishi K; Wakamatsu T; Tanaka T; Adachi T; Fukuda K; Nohara R; Hirota K
Eur J Pharmacol; 2009 Mar; 606(1-3):130-6. PubMed ID: 19374868
[TBL] [Abstract][Full Text] [Related]
68. Comparison of haemodynamic responses to cilnidipine and nicardipine in an experimental model of acute congestive heart failure.
Noguchi K; Matsuzaki T; Koyama T; Itomine T; Sakanashi M
Clin Exp Pharmacol Physiol; 1998; 25(7-8):541-7. PubMed ID: 9673425
[TBL] [Abstract][Full Text] [Related]
69. L-type calcium channel blockade attenuates morphine withdrawal: in vivo interaction between L-type calcium channels and corticosterone.
Esmaeili-Mahani S; Fathi Y; Motamedi F; Hosseinpanah F; Ahmadiani A
Horm Behav; 2008 Feb; 53(2):351-7. PubMed ID: 18177874
[TBL] [Abstract][Full Text] [Related]
70. Assessment of the effects of L- and N-type Ca2+ channel blocking drugs using canine blood-perfused papillary muscle preparations.
Daitoku K; Seya K; Furukawa K; Motomura S
Tohoku J Exp Med; 2007 Aug; 212(4):415-22. PubMed ID: 17660707
[TBL] [Abstract][Full Text] [Related]
71. [Clinical usefulness of a dual L/N-type Ca2+ channel blocker, cilnidipine, in patients with chronic heart failure: assessment with 123I-MIBG myocardial scintigraphy].
Ito K; Sugihara H; Nishikawa S; Adachi Y; Kato S; Azuma A; Matsubara H
Kaku Igaku; 2003 Nov; 40(4):421-30. PubMed ID: 14733106
[TBL] [Abstract][Full Text] [Related]
72. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
73. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
Lee J; Rushlow WJ; Rajakumar N
Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
[TBL] [Abstract][Full Text] [Related]
74. Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes.
Viola HM; Arthur PG; Hool LC
J Mol Cell Cardiol; 2009 Jun; 46(6):1016-26. PubMed ID: 19166857
[TBL] [Abstract][Full Text] [Related]
75. [Effects of sulfur dioxide on cardiac function of isolated perfusion heart of rat].
Zhang SQ; Du JB; Tian Y; Geng B; Tang CS; Tang XY
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):830-4. PubMed ID: 18756988
[TBL] [Abstract][Full Text] [Related]
76. Cilnidipine, a Dual L/N-type Ca
Mehta KK; Tiwaskar M; Kasture P
J Assoc Physicians India; 2024 Apr; 72(4):54-58. PubMed ID: 38881084
[TBL] [Abstract][Full Text] [Related]
77. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
Suzuki S; Ohkusa T; Ono K; Sato T; Yoshida MA; Yano M; Takebayashi S; Matsuzaki M
Circ J; 2007 Dec; 71(12):1970-6. PubMed ID: 18037756
[TBL] [Abstract][Full Text] [Related]
78. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
79. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
[TBL] [Abstract][Full Text] [Related]
80. Influence of chronic treatment of rats with isoprenaline and calcium channel blockers on response of isolated right ventricle to noradrenaline.
Bhugra P; Gulati OD
Indian J Exp Biol; 2001 Mar; 39(3):272-5. PubMed ID: 11495288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
